150 related articles for article (PubMed ID: 28937628)
1. Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma.
Li C; Wang Q; Ma J; Shi S; Chen X; Yang H; Han J
Molecules; 2017 Sep; 22(10):. PubMed ID: 28937628
[TBL] [Abstract][Full Text] [Related]
2. Tracking significant modules and key genes for esophageal squamous cell carcinoma based on differential modules.
Zheng ML; Zhou NK; Luo CH
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1135-S1140. PubMed ID: 30539859
[TBL] [Abstract][Full Text] [Related]
3. [Data mining of esophageal squamous cell carcinoma from The Cancer Genome Atlas database].
He SY; Wang XB; Jiao YC
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):517-522. PubMed ID: 30060360
[No Abstract] [Full Text] [Related]
4. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
He Y; Liu J; Zhao Z; Zhao H
Dis Esophagus; 2017 May; 30(5):1-8. PubMed ID: 28375447
[TBL] [Abstract][Full Text] [Related]
6. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
7. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
[TBL] [Abstract][Full Text] [Related]
8. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Cheng J; Zheng G; Jin H; Gao X
Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
11. An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.
Sawada G; Niida A; Hirata H; Komatsu H; Uchi R; Shimamura T; Takahashi Y; Kurashige J; Matsumura T; Ueo H; Takano Y; Ueda M; Sakimura S; Shinden Y; Eguchi H; Sudo T; Sugimachi K; Yamasaki M; Tanaka F; Tachimori Y; Kajiyama Y; Natsugoe S; Fujita H; Tanaka Y; Calin G; Miyano S; Doki Y; Mori M; Mimori K
PLoS One; 2015; 10(10):e0139808. PubMed ID: 26465158
[TBL] [Abstract][Full Text] [Related]
12. BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.
Zhao Y; Wei L; Shao M; Huang X; Chang J; Zheng J; Chu J; Cui Q; Peng L; Luo Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Nov; 153(5):1304-1319.e5. PubMed ID: 28780075
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma.
Deng F; Zhou K; Li Q; Liu D; Li M; Wang H; Zhang W; Ma Y
Tumour Biol; 2016 Feb; 37(2):1909-18. PubMed ID: 26330293
[TBL] [Abstract][Full Text] [Related]
14. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
15. Microarray expression profile analysis of aberrant long non-coding RNAs in esophageal squamous cell carcinoma.
Yao J; Huang JX; Lin M; Wu ZD; Yu H; Wang PC; Ye J; Chen P; Wu J; Zhao GJ
Int J Oncol; 2016 Jun; 48(6):2543-57. PubMed ID: 27035335
[TBL] [Abstract][Full Text] [Related]
16. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.
Song Y; Li J; Zhu Y; Dai Y; Zeng T; Liu L; Li J; Wang H; Qin Y; Zeng M; Guan XY; Li Y
Oncotarget; 2014 Nov; 5(22):11669-80. PubMed ID: 25375090
[TBL] [Abstract][Full Text] [Related]
20. Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network.
Shen Y; Tantai J; Zhao H
Eur J Med Res; 2014 Oct; 19(1):52. PubMed ID: 25358439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
